FLOLAN Side Effects

7022727-8 | Abdominal Pain, Back Pain, Blood Creatinine Increased, Blood Urea Increased, Constipation, Dehydration, Pain In Extremity
on Sep 24, 2010 Male patient from UNITED STATES , 38 years of age, weighting 154.3 lb, was diagnosed with pulmonary arterial hypertension and was treated with Flolan (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), back pain (What is back pain?), blood creatinine increased, blood urea increased, constipation (What is constipation?), dehydration, pain in extremity. Flolan dosage: . During the same period patient was treated with TYLENOL W/ CODEINE (2tab Three Times Per Day) (View Tylenol W/ Codeine Review and Tylenol W/ Codeine Label ), ASPIRIN (81mg Per Day) (View Aspirin Review and Aspirin Label ), ACETAMINOPHEN (325mg See Dosage Text) (View Acetaminophen Review and Acetaminophen Label ), SIMVASTATIN (40mg At Night) (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

7008358-4 | Convulsion, Fall, Impaired Driving Ability, Subdural Haematoma
Patient was taking Flolan (View Usage). Patient had the following side effects: convulsion, fall (What is fall?), impaired driving ability, subdural haematoma on Sep 15, 2010 from UNITED STATES Additional patient health information: Female patient , 64 years of age, weighting 122.1 lb, . Flolan dosage: . During the same period patient was treated with ASPIRIN (81mg Per Day) (View Aspirin Review and Aspirin Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), ASTELIN (View Astelin Review and Astelin Label ), CRESTOR (View Crestor Review and Crestor Label ), MULTI VITAMIN (1tab Per Day) (View Multi-vitamin Review and Multi-vitamin Label ), FLONASE (View Flonase Review and Flonase Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6985455-0 | Thrombosis
Adverse event was reported on Sep 09, 2010 by a Female patient taking Flolan (View Usage) (Dosage: ) . Location: UNITED STATES , 47 years of age, weighting 152.1 lb, After Flolan was administered, patient had the following side effects: thrombosis. Patient was hospitalized.

6978716-2 | Dizziness, Dyspnoea, Malaise, Underdose
on Sep 02, 2010 Female patient from AUSTRALIA , weighting 167.6 lb, was treated with Flolan (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), dyspnoea, malaise, underdose. Flolan dosage: . During the same period patient was treated with BOSENTAN (125mg Twice Per Day) (View Bosentan Review and Bosentan Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), NORINYL 1+35 28 DAY (View Norinyl 1+35 28-day Review and Norinyl 1+35 28-day Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ).


6968122-9 | Ascites, Dyspnoea, Pain In Extremity, Weight Increased
on Aug 28, 2010 Male patient from JAPAN , 31 years of age, weighting 119.0 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Flolan (View Usage). Patient had the following side effects: ascites, dyspnoea, pain in extremity, weight increased. Flolan dosage: . Patient was hospitalized.

6958335-4 | Hypothyroidism
Patient was taking Flolan (View Usage). After Flolan was administered, patient had the following side effects: hypothyroidism on Aug 18, 2010 from JAPAN Additional patient health information: Female patient , 47 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Flolan dosage: .

6958334-2 | Hypothyroidism
Adverse event was reported on Aug 18, 2010 by a Female patient taking Flolan (View Usage) (Dosage: ) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Location: JAPAN , 55 years of age, Patient experienced the following unwanted or unexpected effects: hypothyroidism.

6958333-0 | Hypothyroidism
on Aug 18, 2010 Female patient from JAPAN , 47 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Flolan (View Usage). Patient had the following side effects: hypothyroidism. Flolan dosage: .

6943902-4 | Thrombosis
on Aug 18, 2010 Female patient from UNITED STATES , 47 years of age, weighting 152.1 lb, was treated with Flolan (View Usage). After Flolan was administered, patient had the following side effects: thrombosis. Flolan dosage: .

6937549-3 | Haemodialysis, Lactic Acidosis, Renal Failure Acute, Septic Shock
Patient was taking Flolan (View Usage). Patient experienced the following unwanted or unexpected effects: haemodialysis, lactic acidosis, renal failure acute, septic shock on Aug 23, 2010 from UNITED STATES Additional patient health information: Male patient , 73 years of age, weighting 218.3 lb, . Flolan dosage: 10 Mcg/ml Continuous Inhal.

6937204-X |
Adverse event was reported on Aug 19, 2010 by a Male patient taking Flolan (View Usage) (Dosage: ) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Location: CANADA , weighting 147.7 lb, .

6932105-5 |
on Jun 13, 2010 Female patient from CANADA , weighting 150.4 lb, was diagnosed with pulmonary arterial hypertension and was treated with Flolan (View Usage). . Flolan dosage: .

6923660-X | Haematocrit Increased, White Blood Cell Count Increased
on Aug 05, 2010 Male patient from JAPAN , weighting 211.6 lb, was diagnosed with pulmonary arterial hypertension, right ventricular failure and was treated with Flolan (View Usage). Patient experienced the following unwanted or unexpected effects: haematocrit increased, white blood cell count increased. Flolan dosage: . During the same period patient was treated with LONGES (10mg Per Day) (View Longes Review and Longes Label ), ALOSITOL (View Alositol Review and Alositol Label ), LUPRAC (View Luprac Review and Luprac Label ), ALLELOCK (10mg Per Day) (View Allelock Review and Allelock Label ), RABEPRAZOLE SODIUM (10mg Per Day) (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), ETHYL ICOSAPENTATE (1800mg Per Day) (View Ethyl Icosapentate Review and Ethyl Icosapentate Label ).

6919367-5 | Adverse Event, Central Venous Catheterisation, Rash, Vaginal Haemorrhage
Patient was taking Flolan (View Usage). Patient had the following side effects: adverse event, central venous catheterisation, rash (What is rash?), vaginal haemorrhage on Aug 03, 2010 from UNITED STATES Additional patient health information: Female patient , 29 years of age, weighting 197.1 lb, was diagnosed with pulmonary arterial hypertension and. Flolan dosage: 16.9ngkm Continuous. During the same period patient was treated with OXYCODONE (5mg As Required) (View Oxycodone Review and Oxycodone Label ), ZOFRAN (4mg As Required) (View Zofran Review and Zofran Label ), ACETAMINOPHEN (650mg As Required) (View Acetaminophen Review and Acetaminophen Label ), PROCHLORPERAZINE (10mg As Directed) (View Prochlorperazine Review and Prochlorperazine Label ).

6917045-X | Cardiac Arrest
Adverse event was reported on Aug 02, 2010 by a Female patient taking Flolan (View Usage) (Dosage: 2ngkm Per Day) was diagnosed with pulmonary arterial hypertension and. Location: COLOMBIA , 32 years of age, After Flolan was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?). Patient was hospitalized.

6812788-0 | Pulmonary Oedema, Pulmonary Vein Occlusion, Pulmonary Veno-occlusive Disease
on Jun 21, 2010 Female patient from JAPAN , 44 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Flolan (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary oedema, pulmonary vein occlusion, pulmonary veno-occlusive disease. Flolan dosage: .

6758523-6 | Interstitial Lung Disease, Thrombocytopenia
on May 28, 2010 Male patient from JAPAN , 74 years of age, was treated with Flolan (View Usage). Patient had the following side effects: interstitial lung disease, thrombocytopenia. Flolan dosage: . Patient was hospitalized.

6751646-7 | Gastrointestinal Haemorrhage, Hypotension, Thrombocytopenia
Patient was taking Flolan (View Usage). After Flolan was administered, patient had the following side effects: gastrointestinal haemorrhage, hypotension, thrombocytopenia on May 25, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 6.61 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?), hypotension and. Flolan dosage: . During the same period patient was treated with NITRIC OXIDE (View Nitric Oxide Review and Nitric Oxide Label ), SILDENAFIL (5.4mg Six Times Per Day) (View Sildenafil Review and Sildenafil Label ), AMPHOTERICIN B (4.2mg Per Day) (View Amphotericin B Review and Amphotericin B Label ), MILRINONE (View Milrinone Review and Milrinone Label ), DOPAMINE HCL (View Dopamine Hcl Review and Dopamine Hcl Label ), FLUCONAZOLE (42mg Per Day) (View Fluconazole Review and Fluconazole Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), ZANTAC (5mg Eight Times Per Day) (View Zantac Review and Zantac Label ). Patient was hospitalized and became disabled.

6746400-6 | Thrombocytopenia
Adverse event was reported on Mar 25, 2010 by a Male patient taking Flolan (View Usage) (Dosage: ) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Location: UNITED STATES , 57 years of age, weighting 156.1 lb, Patient experienced the following unwanted or unexpected effects: thrombocytopenia. During the same period patient was treated with OXYGEN (3lm At Night) (View Oxygen Review and Oxygen Label ), REVATIO (20mg Three Times Per Day) (View Revatio Review and Revatio Label ), TORSEMIDE (100mg Per Day) (View Torsemide Review and Torsemide Label ), SPIRONOLACTONE (25mg Twice Per Day) (View Spironolactone Review and Spironolactone Label ).

6746398-0 | Platelet Count Decreased
on Dec 08, 2009 Male patient from UNITED STATES , child 10 years of age, weighting 59.08 lb, was diagnosed with pulmonary arterial hypertension and was treated with Flolan (View Usage). Patient had the following side effects: platelet count decreased. Flolan dosage: . During the same period patient was treated with SILDENAFIL (30mg Three Times Per Day) (View Sildenafil Review and Sildenafil Label ), DIGOXIN (.125mg Per Day) (View Digoxin Review and Digoxin Label ), LASIX (30mg Twice Per Day) (View Lasix Review and Lasix Label ), SPIRONOLACTONE (25mg Twice Per Day) (View Spironolactone Review and Spironolactone Label ), PREDNISONE TAB (18mg Per Day) (View Prednisone Tab Review and Prednisone Tab Label ), PREVACID (15mg Per Day) (View Prevacid Review and Prevacid Label ), CYCLOSPORINE (80mg Twice Per Day) (View Cyclosporine Review and Cyclosporine Label ), COUMADIN (.5mg Per Day) (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

6746397-9 | Erythema, Osteoporosis
on Nov 13, 2009 Female patient from UNITED STATES , 52 years of age, weighting 136.2 lb, was treated with Flolan (View Usage). After Flolan was administered, patient had the following side effects: erythema, osteoporosis (What is osteoporosis?). Flolan dosage: . During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ).

6746395-5 | Thrombocytopenia
Patient was taking Flolan (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocytopenia on Aug 21, 2009 from UNITED STATES Additional patient health information: Female patient , child 1 years of age, weighting 19.18 lb, was diagnosed with pulmonary arterial hypertension and. Flolan dosage: . During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), LASIX (View Lasix Review and Lasix Label ), FER IN SOL (View Fer-in-sol Review and Fer-in-sol Label ), SILDENAFIL (View Sildenafil Review and Sildenafil Label ), REMODULIN (View Remodulin Review and Remodulin Label ). Patient was hospitalized.

6746394-3 | Headache, Hypoaesthesia, Hypoaesthesia Oral, Migraine
Adverse event was reported on Jul 06, 2009 by a Male patient taking Flolan (View Usage) (Dosage: 57ml Continuous) . Location: UNITED STATES , child 9 years of age, Patient had the following side effects: headache (What is headache?), hypoaesthesia, hypoaesthesia oral, migraine (What is migraine?). During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), MAGNESIUM GLUCONATE (View Magnesium Gluconate Review and Magnesium Gluconate Label ), LASIX (View Lasix Review and Lasix Label ), ZANTAC (View Zantac Review and Zantac Label ), REVATIO (View Revatio Review and Revatio Label ).

6702450-7 | Haematocrit Increased, White Blood Cell Count Increased
on Apr 22, 2010 Male patient from JAPAN , weighting 211.6 lb, was diagnosed with pulmonary arterial hypertension, right ventricular failure and was treated with Flolan (View Usage). After Flolan was administered, patient had the following side effects: haematocrit increased, white blood cell count increased. Flolan dosage: . During the same period patient was treated with LONGES (10mg Per Day) (View Longes Review and Longes Label ), ALOSITOL (View Alositol Review and Alositol Label ), LUPRAC (View Luprac Review and Luprac Label ), ALLELOCK (10mg Per Day) (View Allelock Review and Allelock Label ), PARIET (10mg Per Day) (View Pariet Review and Pariet Label ), ETHYL ICOSAPENTATE (1800mg Per Day) (View Ethyl Icosapentate Review and Ethyl Icosapentate Label ).

6664122-7 | Basedow's Disease, Thyroid Function Test Abnormal
on Mar 26, 2010 Female patient from JAPAN , child 12 years of age, was treated with Flolan (View Usage). Patient experienced the following unwanted or unexpected effects: basedow's disease, thyroid function test abnormal. Flolan dosage: . Patient was hospitalized.

6658160-8 | Cardiac Failure, Respiratory Failure
Patient was taking Flolan (View Usage). Patient had the following side effects: cardiac failure, respiratory failure on Mar 23, 2010 from JAPAN Additional patient health information: Female patient , child 10 years of age, . Flolan dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ).

6581465-6 | Blood Pressure Decreased, Cough, Dyspnoea, Influenza Like Illness, Nausea, Weight Decreased
Adverse event was reported on Feb 11, 2010 by a Male patient taking Flolan (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 34 years of age, After Flolan was administered, patient had the following side effects: blood pressure decreased, cough, dyspnoea, influenza like illness, nausea (What is nausea?), weight decreased. During the same period patient was treated with TRACLEER (View Tracleer Review and Tracleer Label ). Patient was hospitalized.

6568497-9 | Cardiac Failure, Respiratory Failure
on Jan 28, 2010 Female patient from JAPAN , child 10 years of age, was treated with Flolan (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, respiratory failure. Flolan dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ).

6393537-X | Blood Creatine Phosphokinase Increased, Feeling Abnormal, Hyperhidrosis, Malaise, Product Quality Issue, Vision Blurred
on Sep 25, 2009 Female patient from FRANCE , 60 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Flolan (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, feeling abnormal, hyperhidrosis, malaise, product quality issue, vision blurred. Flolan dosage: . Patient was hospitalized.

6359859-3 | Blood Creatine Phosphokinase Increased, Feeling Abnormal, Hyperhidrosis, Malaise, Product Quality Issue, Vision Blurred
Patient was taking Flolan (View Usage). After Flolan was administered, patient had the following side effects: blood creatine phosphokinase increased, feeling abnormal, hyperhidrosis, malaise, product quality issue, vision blurred on Sep 08, 2009 from FRANCE Additional patient health information: Female patient , 60 years of age, was diagnosed with pulmonary arterial hypertension and. Flolan dosage: . Patient was hospitalized.

6356485-7 |
Adverse event was reported on Sep 14, 2009 by a Male patient taking Flolan (View Usage) (Dosage: ) . Location: CANADA , weighting 352.7 lb, .

6343707-1 | Cerebral Haemorrhage, Haemorrhagic Stroke, Subdural Haematoma
on Sep 04, 2009 Female patient from UNITED STATES , 77 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Flolan (View Usage). Patient had the following side effects: cerebral haemorrhage, haemorrhagic stroke, subdural haematoma. Flolan dosage: . During the same period patient was treated with TRACLEER (125mg Twice Per Day) (View Tracleer Review and Tracleer Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

6301472-8 | Blister, Hypersensitivity, Rash, Swelling
on Jul 31, 2009 Female patient from UNITED STATES , 26 years of age, weighting 131.2 lb, was diagnosed with gastrointestinal disorder and was treated with Flolan (View Usage). After Flolan was administered, patient had the following side effects: blister, hypersensitivity, rash (What is rash?), swelling. Flolan dosage: . During the same period patient was treated with EPOPROSTENOL SODIUM (View Epoprostenol Sodium Review and Epoprostenol Sodium Label ), REMODULIN (View Remodulin Review and Remodulin Label ), REVATIO (View Revatio Review and Revatio Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), TRACLEER (View Tracleer Review and Tracleer Label ), WARFARIN (View Warfarin Review and Warfarin Label ), OXYGEN (View Oxygen Review and Oxygen Label ), PEPCID (View Pepcid Review and Pepcid Label ). Patient was hospitalized.

6296482-3 | Cerebral Haemorrhage, Haemorrhagic Stroke
Patient was taking Flolan (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, haemorrhagic stroke on Jul 27, 2009 from UNITED STATES Additional patient health information: Female patient , 77 years of age, was diagnosed with pulmonary arterial hypertension and. Flolan dosage: . During the same period patient was treated with TRACLEER (125mg Twice Per Day) (View Tracleer Review and Tracleer Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

6284875-X | Atrial Septal Defect, Catheter Site Infection, Haemoptysis, Paradoxical Embolism, Transient Ischaemic Attack
Adverse event was reported on Jul 15, 2009 by a Female patient taking Flolan (View Usage) (Dosage: ) . Location: SPAIN , 27 years of age, Patient had the following side effects: atrial septal defect, catheter site infection, haemoptysis, paradoxical embolism, transient ischaemic attack. During the same period patient was treated with REMODULIN (View Remodulin Review and Remodulin Label ), VENTAVIS (View Ventavis Review and Ventavis Label ), ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), OXYGEN (2lm Per Day) (View Oxygen Review and Oxygen Label ), TRACLEER (250mg Per Day) (View Tracleer Review and Tracleer Label ), VIAGRA (75mg Per Day) (View Viagra Review and Viagra Label ). Patient was hospitalized.

6259887-2 | Ascites, Body Temperature Decreased, Cachexia, Diarrhoea, Fatigue, Pleural Effusion, Polyserositis, Weight Decreased
on Jul 02, 2009 Female patient from UNITED STATES , 55 years of age, weighting 109.3 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Flolan (View Usage). After Flolan was administered, patient had the following side effects: ascites, body temperature decreased, cachexia, diarrhoea, fatigue, pleural effusion, polyserositis, weight decreased. Flolan dosage: 28.5ng/kg/min Wt=44kg Continuous Iv Drip. Patient was hospitalized.

6257080-0 | Cardiac Failure, Fatigue, Pancytopenia, Systemic Lupus Erythematosus, Ventricular Tachycardia
on Jun 29, 2009 Female patient from JAPAN , weighting 103.6 lb, was diagnosed with collagen disorder and was treated with Flolan (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, fatigue, pancytopenia, systemic lupus erythematosus, ventricular tachycardia. Flolan dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ).

6254622-6 | Blister, Rash, Swelling
Patient was taking Flolan (View Usage). Patient had the following side effects: blister, rash (What is rash?), swelling on Jun 26, 2009 from UNITED STATES Additional patient health information: Female patient , 26 years of age, weighting 131.2 lb, . Flolan dosage: . During the same period patient was treated with EPOPROSTENOL SODIUM (View Epoprostenol Sodium Review and Epoprostenol Sodium Label ), REMODULIN (View Remodulin Review and Remodulin Label ). Patient was hospitalized.

6252952-5 |
Adverse event was reported on Jun 23, 2009 by a Female patient taking Flolan (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: JAPAN , weighting 110.2 lb, . During the same period patient was treated with WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ), FUROSEMIDE INTENSOL (View Furosemide Intensol Review and Furosemide Intensol Label ).

6252951-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Cardiac Failure, Hepatic Congestion, Hepatic Function Abnormal, Hyperthyroidism, Idiopathic Thrombocytopenic Purpura, Liver Disorder, Thyroiditis
on Jun 30, 2009 Female patient from JAPAN , weighting 94.80 lb, was diagnosed with pulmonary arterial hypertension and was treated with Flolan (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, cardiac failure, hepatic congestion, hepatic function abnormal, hyperthyroidism, idiopathic thrombocytopenic purpura, liver disorder, thyroiditis. Flolan dosage: . During the same period patient was treated with TAKEPRON (15mg Per Day) (View Takepron Review and Takepron Label ), FUROSEMIDE INTENSOL (40mg Per Day) (View Furosemide Intensol Review and Furosemide Intensol Label ), SPIRONOLACTONE (25mg Per Day) (View Spironolactone Review and Spironolactone Label ), LAC B (3g Per Day) (View Lac B Review and Lac B Label ), URALYT URATO (3g Per Day) (View Uralyt Urato Review and Uralyt Urato Label ), URINORM (18mg Per Day) (View Urinorm Review and Urinorm Label ), LOPEMIN (1mg Per Day) (View Lopemin Review and Lopemin Label ), ENSURE (View Ensure Review and Ensure Label ). Patient was hospitalized.

6247352-8 | Anorexia, Catheter Related Infection, Catheter Site Pain, Diarrhoea, Nausea, Oesophageal Hypomotility, Purulent Discharge, Pyrexia, Staphylococcal Infection
on Jun 22, 2009 Female patient from JAPAN , weighting 114.6 lb, was diagnosed with mixed connective tissue disease and was treated with Flolan (View Usage). Patient had the following side effects: anorexia, catheter related infection, catheter site pain, diarrhoea, nausea (What is nausea?), oesophageal hypomotility, purulent discharge, pyrexia, staphylococcal infection (What is staphylococcal infection?). Flolan dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), PARIET (View Pariet Review and Pariet Label ), BIOFERMIN (View Biofermin Review and Biofermin Label ), GASCON (View Gascon Review and Gascon Label ). Patient was hospitalized.

6240998-2 | Basedow's Disease, Cardiac Failure, Catheter Related Infection, Catheter Removal, Pulmonary Haemorrhage, Tachycardia, Tremor, Weight Decreased
Patient was taking Flolan (View Usage). After Flolan was administered, patient had the following side effects: basedow's disease, cardiac failure, catheter related infection, catheter removal, pulmonary haemorrhage, tachycardia, tremor, weight decreased on Jun 17, 2009 from JAPAN Additional patient health information: Female patient , weighting 92.59 lb, was diagnosed with pulmonary arterial hypertension and. Flolan dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ), WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ), SLOW K (View Slow-k Review and Slow-k Label ), MEDICON (View Medicon Review and Medicon Label ), FERO GRADUMET (View Fero-gradumet Review and Fero-gradumet Label ), CINAL (View Cinal Review and Cinal Label ). Patient was hospitalized.

6229647-7 | Haemoptysis, Hypoxia
Adverse event was reported on Jun 05, 2009 by a Female patient taking Flolan (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension, cardiac failure, prophylaxis and. Location: JAPAN , weighting 92.59 lb, Patient experienced the following unwanted or unexpected effects: haemoptysis, hypoxia. During the same period patient was treated with WARFARIN POTASSIUM (2mg Per Day) (View Warfarin Potassium Review and Warfarin Potassium Label ), FUROSEMIDE (20mg Per Day) (View Furosemide Review and Furosemide Label ), NIFEDIPINE (40mg Per Day) (View Nifedipine Review and Nifedipine Label ), TRACLEER (250mg Per Day) (View Tracleer Review and Tracleer Label ), ACARDI (2.5mg Per Day) (View Acardi Review and Acardi Label ), DOBUTREX (View Dobutrex Review and Dobutrex Label ), CEFAMEZIN (2g Per Day) (View Cefamezin Review and Cefamezin Label ). Patient was hospitalized.

6229646-5 | Hypoxia
on Jun 05, 2009 Female patient from JAPAN , 24 years of age, weighting 92.59 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?), infection (What is infection?), gastric ulcer, cardiac failure and was treated with Flolan (View Usage). Patient had the following side effects: hypoxia. Flolan dosage: . During the same period patient was treated with BERAPROST SODIUM (View Beraprost Sodium Review and Beraprost Sodium Label ), SEPAMIT (40mg Per Day) (View Sepamit Review and Sepamit Label ), TRACLEER (View Tracleer Review and Tracleer Label ), CEFAMEZIN (2g Per Day) (View Cefamezin Review and Cefamezin Label ), ZANTAC (View Zantac Review and Zantac Label ), DOPAMINE HYDROCHLORIDE (View Dopamine Hydrochloride Review and Dopamine Hydrochloride Label ), DOBUTREX (View Dobutrex Review and Dobutrex Label ).

6218354-2 | Pulmonary Hypertension
on May 29, 2009 Female patient from UNITED STATES , 41 years of age, was treated with Flolan (View Usage). After Flolan was administered, patient had the following side effects: pulmonary hypertension (What is pulmonary hypertension?). Flolan dosage: . During the same period patient was treated with POLYPHARMACY (View Polypharmacy Review and Polypharmacy Label ).

6207929-2 | Abdominal Distension, Bacteria Urine Identified, Dehydration, Dyspnoea, Eructation, Flatulence, Haemoglobin Decreased, Heart Rate Increased, Heart Rate Irregular
Patient was taking Flolan (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, bacteria urine identified, dehydration, dyspnoea, eructation, flatulence, haemoglobin decreased, heart rate increased, heart rate irregular on Aug 22, 2008 from UNITED STATES Additional patient health information: Female patient , 69 years of age, weighting 119.0 lb, was diagnosed with pulmonary arterial hypertension and. Flolan dosage: 30ngkm See Dosage Text. During the same period patient was treated with APAP TAB (325mg As Required) (View Apap Tab Review and Apap Tab Label ), IMODIUM (2mg As Required) (View Imodium Review and Imodium Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), COUMADIN (7.5mg Per Day) (View Coumadin Review and Coumadin Label ), SPIRONOLACTONE (50mg Per Day) (View Spironolactone Review and Spironolactone Label ), TRACLEER (62.5mg Twice Per Day) (View Tracleer Review and Tracleer Label ), HYDROCODONE BITARTRATE + ACETAMINOPHEN (View Hydrocodone Bitartrate + Acetaminophen Review and Hydrocodone Bitartrate + Acetaminophen Label ).

6207927-9 | Nausea, Weight Decreased
Adverse event was reported on Jun 25, 2008 by a Female patient taking Flolan (View Usage) (Dosage: ) . Location: UNITED STATES , 37 years of age, Patient had the following side effects: nausea (What is nausea?), weight decreased.

6207926-7 | Procedural Complication
on Aug 04, 2008 Female patient from UNITED STATES , 47 years of age, weighting 110.2 lb, was diagnosed with pulmonary arterial hypertension and was treated with Flolan (View Usage). After Flolan was administered, patient had the following side effects: procedural complication. Flolan dosage: . During the same period patient was treated with VICODIN (View Vicodin Review and Vicodin Label ), PROMETHAZINE (25mg As Required) (View Promethazine Review and Promethazine Label ), MEGESTROL ACETATE (4tsp Per Day) (View Megestrol Acetate Review and Megestrol Acetate Label ), SPIRIVA (1puff Per Day) (View Spiriva Review and Spiriva Label ), NORVASC (10mg Per Day) (View Norvasc Review and Norvasc Label ), FUROSEMIDE (40mg Per Day) (View Furosemide Review and Furosemide Label ), ATIVAN (1mg Four Times Per Day) (View Ativan Review and Ativan Label ), VALIUM (5mg Per Day) (View Valium Review and Valium Label ).

6170119-6 | Cardiac Failure, Fatigue, Pancytopenia, Systemic Lupus Erythematosus, Ventricular Tachycardia
on Apr 24, 2009 Female patient from JAPAN , weighting 103.6 lb, was diagnosed with collagen disorder and was treated with Flolan (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, fatigue, pancytopenia, systemic lupus erythematosus, ventricular tachycardia. Flolan dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ).

6170079-8 |
Patient was taking Flolan (View Usage). on Apr 22, 2009 from CANADA Additional patient health information: Female patient , weighting 138.2 lb, . Flolan dosage: .